|
Hiromi Yoshikawa was appointed Chairman and CEO of Otsuka America Pharmaceutical, Inc. (OAPI) in 2000, following 26 years of diverse and progressively responsible positions with Otsuka Pharmaceutical Co., Ltd. (OPC). Since Mr. Yoshikawa has undertaken this position, the company has experienced solid revenue growth.
Mr. Yoshikawa joined Otsuka Pharmaceutical Co., Ltd. (OPC) in April 1976, where he worked in the Computer System Section of Otsuka's Finance Department. He was transferred to Japan Immunoresearch Laboratories (JIMRO) when it was acquired by OPC in December 1977, and appointed as a manager in the Accounting Department. Three years later, OPC assigned Mr. Yoshikawa to install an electronic integrated management system for China Otsuka, an OPC subsidiary that was established in 1981. (China Otsuka was the first joint venture between a Japanese private company and the China National Pharmaceutical Industry Corporation).
During this time, Mr. Yoshikawa mastered his skills in systems engineering and basic computer languages and was assigned to a Tokushima factory to build its cost accounting system. During his nine years in Tokushima, Mr. Yoshikawa learned about product manufacturing. He then spent three years in the Finance Department of OPC's Tokyo head office before moving to London in 1997 to establish Otsuka business entities in Europe. There, he investigated local and international taxation, as well as the health care system of each European country, becoming deeply involved in corporate planning and finance for the new OPC Europe companies and establishing the foundation for Otsuka's business organization overseas.
In addition to his position as Chairman and CEO of OAPI, Mr. Yoshikawa is a member of the Board of Directors of Otsuka Pharmaceutical Co., Ltd. (OPC), and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). He is Chairman of the Board of Otsuka Maryland Medicinal Laboratories, Inc. (OMML), Otsuka Pharmaceutical Europe, Ltd. (OPEL), as well as Otsuka America, Inc., which gives him responsibility for Otsuka's consumer product organizations in the US as well as the three Otsuka America Pharmaceutical companies (OAPI, OPDC and OMML). He is also responsible for overseeing all Otsuka pharmaceutical businesses around the globe.
Mr. Yoshikawa was born in Tokyo, Japan where he received his Bachelor's degree in Business from Waseda University | 